Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Study reveals heart failure device could monitor patients and prevent hospitalisation

Study reveals heart failure device could monitor patients and prevent hospitalisation
p p Read More

Heart failure is a cardiovascular disease that affects more than 64 million people worldwide

May 14, 2024 Analog Devices Inc, cardiovascular conditions, heart failure, News, Sensinel Cardiopulmonary Management System, University of Glasgow

MIT’s new MRI brain light-detecting technique could support brain cell studies

Bioluminescence used MRI to observe the dilation of luciferase in engineered blood vessels

May 13, 2024 bioluminescence, brain cells, luciferase, Massachusetts Institute of Technology, MRI, News

PharmaTimes MSEA and NIEA awards are open for entry

Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place […]

May 13, 2024 Medical & Scientific Awards 2024, News, Nursing Industry Excellence Awards 2024, PharmaTimes

BBSRC invests £48m in Babraham Institute to advance lifelong health research

The funding will help to support research across epigenetics, immunology and cell signalling

May 13, 2024 Babraham Institute, Biotechnology and Biological Sciences Research Council, cell signalling, epigenetics, Immunology, Life sciences, News, research and development

NHS reduces long waits for cancer care and achieves faster ambulance responses

For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer

May 10, 2024 ambulance responses, cancer diagnosis, Cancer treatment, News, NHS England

MHRA’s AI Airlock to address challenges for regulating AI medical devices

The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance

May 10, 2024 AI Airlock, AI as a Medical Device, artificial intelligence, Medicines and Healthcare products Regulatory Agency, News, regulatory sandbox

Oregon and Lantern collaborate to develop drug candidate for various cancer indications

Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024

May 9, 2024 artificial intelligence, Lantern Pharma, News, Oregon Therapeutics, protein disulfide isomerase, RADR AI, XCE853

OneChain’s CAR T trial treats its first cortical T-cell ALL patient

The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too […]

May 9, 2024 CARxALL, cortical T-cell acute lymphoblastic leukaemia, News, OC-1, oncological diseases, OneChain Immunotherapeutics

Johns Hopkins scientists depict molecular pathway to track replication in cancer cells

The findings could potentially lead to new therapies and could stop the growth of cancers

May 8, 2024 anaphase-promoting complex, Cancer, cell cyles, cyclin dependent kinases, Johns Hopkins Medicine, News, Oncology

Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases

Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications

May 8, 2024 Chiesi Group, Gossamer Bio, News, Pulmonary Arterial Hypertension, pulmonary hypertension associated with interstitial lung disease, respiratory diseases, seralutinib

Posts navigation

Posts pagination

« Previous 1 … 53 54 55 … 72 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy